Advertisement

Topics

"Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)" Drugs and Medication Database

18:56 EST 21st January 2019 | BioPortfolio

Here are the most relevant "Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)" Drugs and Medications that we have found in our database.

More Information about "Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)" on BioPortfolio

We have published hundreds of Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) news stories on BioPortfolio along with dozens of Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) Clinical Trials and PubMed Articles about Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) Companies in our database. You can also find out about relevant Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) Drugs and Medications on this site too.

Showing "Insulin Glargine Type Diabetes Mellitus Main Study quot" Drugs and Medications 1–25 of 571

Probably Relevant

Byetta [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA (exenatide) Injection Initial U.S. Approval: 2005

Basaglar [Eli Lilly and Company]

These highlights do not include all the information needed to use BASAGLAR safely and effectively. See full prescribing information for BASAGLARBASAGLAR (insulin glargine injection), for subcutaneous useInitial U.S. Approval: 2000

Levemir [REMEDYREPACK INC.]

These highlights do not include all the information needed to use LEVEMIR safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR (insulin detemir [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20

Levemir [REMEDYREPACK INC.]

These highlights do not include all the information needed to use LEVEMIR safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR (insulin detemir [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20

Levemir [A-S Medication Solutions]

These highlights do not include all the information needed to use LEVEMIR safely and effectively.See full prescribing information for LEVEMIR.LEVEMIR (insulin detemir [rDNA origin] injection) solution for subcutaneous injectionInitial U.S. Approval: 2005

Levemir [Novo Nordisk]

These highlights do not include all the information needed to use LEVEMIR safely and effectively.See full prescribing information for LEVEMIR.LEVEMIR (insulin detemir [rDNA origin] injection) solution for subcutaneous injectionInitial U.S. Approval: 2005

Byetta [AstraZeneca Pharmaceuticals LP]

These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA® (exenatide) injection, for subcutaneous useInitial U.S. Approval: 2005

Soliqua 100/33 [Sanofi-Aventis U.S. LLC]

These highlights do not include all the information needed to use SOLIQUA 100/33 safely and effectively. See full prescribing information for SOLIQUA 100/33. SOLIQUA 100/33 (insulin glargine and lixisenatide injection), for subcutaneous use Initial U.S. A

Possibly Relevant

Nesina [Takeda Pharmaceuticals America, Inc.]

These highlights do not include all the information needed to use NESINA safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013

Alogliptin [Perrigo New York Inc]

These highlights do not include all the information needed to use ALOGLIPTIN TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN TABLETS. Alogliptin Tablets, for oral use Initial U.S. Approval: 2013

Miglitol [Orient Pharma Co., Ltd.]

Miglitol Tablets

Glipizide er [DirectRX]

GLIPIZIDE ER

Glyset [Pharmacia and Upjohn Company LLC]

Glyset (miglitol) tablets

Miglitol [Sun Pharmaceutical Industries Ltd.]

Miglitol TabletsThese highlights do not include all the information needed to use Miglitol safely and effectively.See full prescribing information for MiglitolMiglitol (Miglitol) TABLET, COATED for ORAL use.Initial U.S. Approval:

Toujeo [A-S Medication Solutions]

These highlights do not include all the information needed to use TOUJEO safely and effectively. See full prescribing information for TOUJEO. TOUJEO (insulin glargine injection) U-300, for subcutaneous useInitial U.S. Approval: 2015

Toujeo [Sanofi-Aventis U.S. LLC]

These highlights do not include all the information needed to use TOUJEO safely and effectively. See full prescribing information for TOUJEO. TOUJEO (insulin glargine injection) U-300, for subcutaneous use Initial U.S. Approval: 2015

Januvia [A-S Medication Solutions]

These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA (sitagliptin) TabletsInitial U.S. Approval: 2006

Levemir [Dispensing Solutions, Inc.]

Levemir (insulin detemir [rDNA origin] injection)

Januvia [Clinical Solutions Wholesale]

These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA (sitagliptin) TabletsInitial U.S. Approval: 2006

Fiasp [Novo Nordisk]

These highlights do not include all the information needed to use FIASP safely and effectively. See full prescribing information for FIASP.FIASP (insulin aspart injection) for subcutaneous or intravenous useInitial U.S. Approval: 2000

Levemir [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use LEVEMIR safely and effectively.See full prescribing information for LEVEMIR.LEVEMIR (insulin detemir [rDNA origin] injection) solution for subcutaneous injectionInitial U.S. Approval: 2005

Lantus solostar [REMEDYREPACK INC.]

These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine injection) solution for subcutaneous injection Initial U.S. Approval: 2000

Lantus solostar [A-S Medication Solutions]

These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine injection) solution for subcutaneous injectionInitial U.S. Approval: 2000

Lantus [A-S Medication Solutions]

These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine injection) solution for subcutaneous injectionInitial U.S. Approval: 2000

Lantus [TYA Pharmaceuticals]

These highlights do not include all the information needed to use LANTUS safely and effectively. See full prescribing information for LANTUS. LANTUS (insulin glargine [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 2000



Advertisement
Quick Search
Advertisement
Advertisement